Related Experiment Video
Updated: Sep 26, 2026

Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages
Published on: May 30, 2013
Development of microbial-human enterocyte interaction: cholera toxin
Lei Lu1, Manuel E Baldeon, Tor Savidge
1Combined Program in Pediatric Gastroenterology and Nutrition, Harvard Medical School, Director, Developmental Gastroenterology Laboratory, Massachusetts General Hospital, 114 16th Street (114-3503), Charlestown, MA 02129-4404, U.S.A.
Insights
Infant diarrhea is a global health risk. This study shows immature human intestines are more susceptible to cholera toxin due to developmental changes, impacting infant infectious disease strategies.
Area of Science:
- Gastroenterology
- Pediatric Infectious Diseases
- Developmental Biology
Background:
- Diarrhea poses a significant global health threat to infants and children.
- Neonatal period presents increased severity and incidence of certain toxigenic diarrheas.
- Previous research indicated developmental differences in cholera toxin-induced secretion in animal models.
Purpose of the Study:
- To investigate the role of human intestinal development in cholera toxin-induced secretion.
- To determine if developmental up-regulation of signaling pathways contributes to enhanced susceptibility in immature intestines.
Main Methods:
- Utilized experimental models of human intestinal development, including fetal cell lines.
- Employed a micro-Ussing chamber for physiological measurements.
- Incorporated organ cultures and fetal intestinal xenograft transplants for comprehensive analysis.
Main Results:
- Provided preliminary evidence of enhanced cholera toxin secretion in immature human small intestine.
- Indicated a developmental up-regulation of the cyclic adenosine monophosphate (cAMP) response in immature intestines.
- Identified potential up-regulation of postreceptor signal transduction molecules.
Conclusions:
- Immature human small intestine exhibits an enhanced secretory response to cholera toxin, partly due to developmental up-regulation of the cAMP pathway.
- Further research is necessary to elucidate other developmental factors, such as receptor expression.
- Findings may inform strategies for preventing and treating infant cholera and other age-related intestinal infections.
Abstract:
Diarrhea in infants and children is a major health hazard worldwide. Certain toxigenic diarrheas occur more commonly and are manifested more severely during the neonatal period. We have previously studied the regulation of cholera toxin-induced secretion in animal models during development. In those studies we have shown that cholera toxin stimulates a much greater secretion by immature compared with mature small intestine, and the mechanism appears to be an up-regulation of postreceptor signal transduction molecules (adenyl cyclase and Gsalpha) leading to an elevated cAMP level. In this study, using experimental models of human intestinal development (fetal cell lines, a micro-Ussing chamber, organ cultures, and fetal intestinal xenograft transplants), we provide preliminary evidence that cholera toxin induces an enhanced secretion mediated in part by a developmental up-regulation of the cAMP response in immature versus mature human small intestine. Additional studies are needed, however, to further define whether other developmental events (e.g. receptor expression) also regulate cholera toxin-enterocyte-enhanced interaction. Nonetheless, this approach to determining the role of development in the pathophysiology of cholera in infants may help in strategies to prevent and treat this condition and other age-related intestinal infectious diseases.
Related Concept Videos
Cholera
Bacterial Gastroenteritis
Bacterial Toxins
Development of Human Microbiota

